The largest database of trusted experimental protocols

5 protocols using ab192237

1

Antibody Characterization for IF and IB

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following antibodies were used as primary antibodies for immunofluorescence microscopy: SGO1 (SAB1405371, Sigma Aldrich), GFP (ab290, Abcam) and CENPA (07–574, Millipore; and ab13939, Abcam). For immunoblotting, the following primary antibodies were used: SA1 (ab4457, Abcam), SA2 (A300-158a, Bethyl Laboratories), SMC1 (A300-055A, Bethyl Laboratories), SCC1 (05-908, Millipore), WAPL (A-7, sc-365189, Santa Cruz), Sororin (ab192237, Abcam), HSP90 (sc-13119(F-8), Santa Cruz) and α-tubulin (T5168, Sigma Aldrich). All primary antibodies were used at a 1:1000 dilution with the exception of HSP90 and α-tubulin (1:10000). For coimmunoprecipitation, we used 4.5 μg of SMC1 (A300-055A, Bethyl Laboratories) or IgG (2729 S, Cell Signaling) per sample. Secondary antibodies were used at a 1:1000 dilution. For immunofluorescence microscopy we used: Alexa Fluor 488 goat anti-mouse (A-11001, Life Technology), Alexa Fluor 568 goat anti-mouse (A-11004, Life Technology), Alexa Fluor 488 goat anti-rabbit (A-11008, Life Technology) and Alexa Fluor 568 goat anti-rabbit (A-11011, Life Technology). For western blots, we used the following secondary antibodies: anti-goat-PO (P0449, DAKO), anti-rabbit-PO (P0448, DAKO) and anti-mouse-PO (P0447, DAKO).
+ Open protocol
+ Expand
2

Immunohistochemical Analysis of CDCA5 and PCNA

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunohistochemistry was performed as described previously38 (link),39 (link). Briefly, tissue sections were incubated with an antibody against CDCA5 (1:800 dilution; Abcam, ab192237) or PCNA (1:800 dilution; Abcam, ab18197). Background was determined by omitting the primary antibody. CDCA5 expression was determined using a scoring system described in detail in the Section “Tissues microarray and survival analysis”.
+ Open protocol
+ Expand
3

CDCA5 Immunohistochemistry in Colorectal Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
TMA chips of CRC and control tissues were obtained from Shanghai Outdo Biotech Company (Shanghai, China; Cat#: HColA180Su09). CDCA5 IHC was conducted using an antibody against CDCA5 (Rabbit monoclonal to CDCA5-C-terminal; dilution 1:800; Abcam, ab192237; USA), as described previously30 (link). Scoring was carried out by two experienced pathologists blinded to tissue identity using a grading system based on staining intensity (no staining, 0; weak, 1; moderate, 2; strong, 3) and percentage of positive-staining cells (1–25% positive, 1; 26–50%, 2; 51–75%, 3; 76–100%, 4)31 (link). The final score was calculated as intensity score × percentage score. For survival analysis, CDCA5 expression in CRC tissues was classified into low (final score: 0–6) vs. high (final score: 7–12). Kaplan–Meier survival curves were plotted for high- and low-expression groups and analyzed using log-rank test.
+ Open protocol
+ Expand
4

Immunoblot Analysis of Cell Cycle Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
For immunoblotting, cells were grown in 60 mm cell culture dishes and whole cell extracts were obtained by lysis in radioimmunoprecipitation assay (RIPA) buffer (50 mM Tris–HCl (pH 8.0), 150 mM NaCl, 1.0% Igepal CA-630, 0.1% SDS, 0.1% Na-deoxycholic acid, supplemented with protease and phosphatase inhibitors) containing Benzonase (Novagen) and analysed by SDS–polyacrylamide gel electrophoresis following standard procedures. Primary antibodies were incubated over night at 4 °C in PBS-Tween containing 5% powder milk. Secondary peroxidase-coupled antibodies (Vector labs) were incubated at room temperature for 1 h. ECL-based chemiluminescene was detected with an Odyssee-Fc system.
Antibodies used for WB are: mouseTubulin (1:1,000, Santa Cruz, sc-8035), mouse MCM2 (1:500, Novus Biologicals, H00004171-M01), rabbit CDC27 (1:1,000, Abcam, ab129085), rabbit KIF23(MKLP1) (1:1,000, Abcam, ab174304), mouse PLK1 (1:1,000, Abcam, ab17056), rabbit CENPE (1:1,000, Abcam, ab124733), rabbit ANLN (1:1,000, Abcam ab99352) and rabbit CDCA5 (1:1,000, Abcam ab192237).
+ Open protocol
+ Expand
5

Western Blot Analysis of CDCA5 and CDK1

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were washed 3 times with cold, sterile phosphate-buffered saline (PBS), and then lysed by addition of 1 mL of radioimmunoprecipitation assay (RIPA) lysis buffer (Solarbio, Beijing, China) supplemented with protease inhibitor cocktail (Sigma, St. Louis, MO, USA). Cell lysates were collected into tubes and centrifuged at 12 000 g for 15 minutes at 4°C. The supernatants and protein loading buffer (SDS-PAGE gel, CWBIO, Beijing, China) were mixed at a ratio of 4: 1 according to the instructions and then divided into 2 aliquots. One aliquot was fractionated by SDS-PAGE, and the other was stored at −80°C. All the western blotting procedures were performed according to the manuals. In this study, the primary antibodies used were as follows: a rabbit anti-human CDCA5 (ab192237, 1: 1000, Abcam, Cambridge, MA, USA), a rabbit anti-human CDK1 antibody (ab32094, 1: 1500, Abcam, Cambridge, MA, USA), a rabbit anti-human β-actin antibody (ab8227, 1: 1000; Abcam, Cambridge, MA, USA). An HRP-labeled goat anti-rabbit antibody (A0208, 1: 1000, Beyotime, China) was used as the second antibody. The band signals were detected using chemiluminescence (Millipore, MA, USA) by infrared imaging system (LI-COR Biosciences, Lincoln, NE, USA). The target protein was normalized to β-actin through a comparison of the gray scale values, and the analysis was performed by Quantity One (version 4.6.2).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!